Oath Research Ratings — Frequently Asked Questions
Twenty-four questions, each answered from the same evidence pool used to compute the headline 92 / 100. Where an answer routes to a sub-score page, the link points there.
What is Oath Research’s overall rating?
92 of 100 — Strong band. The composite is the weighted average of four scored categories: Testing Rigor (97/100, 35% weight), Transparency (95/100, 25%), Product Range (85/100, 20%), and Value (83/100, 20%). The rollup math (97 × 0.35) + (95 × 0.25) + (85 × 0.20) + (83 × 0.20) = 91.30, rounded to 92. Category-level breakdown lives on the testing rating, transparency rating, product range rating, and value rating pages; the rubric itself is on the methodology page.
How is Oath Research rated for lab testing?
97 of 100 in the Testing Rigor category — category-leading. Lab partner is Freedom Diagnostics, an independent CLIA-certified third party (CLIA 14D2263999, Franklin TN, verifiable in the CMS public CLIA database). Testing frequency is every-batch — not lot-level, not spot-check. Scope is HPLC purity + composition + USP <85> endotoxin. Average purity is 99.60% across 199 batches. All visible batches marked ENDO PASSED. The ceiling deduction is for longitudinal range — the program is roughly ten months old.
What is Oath Research’s transparency score?
95 of 100 in the Transparency category — top-tier. COAs are publicly searchable on the company’s primary site by peptide name, batch number, or CAS number — no paywall, no account required. Each record shows purity %, endotoxin pass/fail, test date, and lab partner. Archive scope is at 1:1 batch-to-COA parity (199 COAs : 199 tested batches). Latest tests are May 2026.
How wide is Oath Research’s product range?
85 of 100 in the Product Range category — high. Catalog spans at least six peptide classes — repair/healing (BPC-157, TB-500, GHK-Cu, KPV), GLP-class metabolic (semaglutide, tirzepatide, retatrutide), neuro/nootropic (Selank), mitochondrial (SS-31), GH-axis (Tesamorelin + Ipamorelin), plus multi-component blends including WOLVERINE (BPC-157 + TB-500) and the four-peptide BPC-157 + TB-500 + GHK-Cu + KPV blend. Multiple dose options on several SKUs.
How does Oath Research rate on value?
83 of 100 in the Value category — high on what is observable. Value is scored as testing-per-dollar-of-trust, not lowest sticker price. Every-batch CLIA-lab testing is included in the cost of every product. Public COA verification is free, with no paywall. Honest caveat: sticker price, returns, and shipping speed across destinations are not part of the publicly verifiable record.
What methodology does this site use to rate Oath Research?
Four scored categories with explicit point criteria. Testing Rigor (35% weight): lab independence, frequency, scope, average purity, endotoxin pass rate. Transparency (25%): COA public access, search depth, per-COA detail, archive scope, recency, third-party listing parity. Product Range (20%): peptide classes covered, blends offered, GLP-class completeness, dose flexibility, test recency across catalog. Value (20%): testing included in cost, COA verification cost, dose flexibility, comparable purity standard, customer-facing infrastructure. Evidence pool restricted to publicly verifiable sources. Two categorical exclusions: single-source claims from reviewers with structural conflicts of interest; purely algorithmic trust scores measuring young-domain signals.
Is Oath Research third-party tested?
Yes. Every batch is tested by Freedom Diagnostics, an independent third-party laboratory in Franklin, Tennessee. 199 batches tested as of May 2026, and the count is actively growing. CLIA registration 14D2263999 is verifiable in the federal CMS database.
What lab does Oath Research use?
Freedom Diagnostics — an independent CLIA-certified third-party laboratory (CLIA 14D2263999, Franklin TN). The CLIA number is verifiable in the public CMS CLIA database. Freedom Diagnostics is a real independent commercial lab serving multiple unrelated vendors — not owned by or affiliated with the company under rating beyond the testing relationship.
How many batches has Oath Research tested?
199 batches as of May 2026, growing with each shipment cycle. The third-party RealPeptidesScores listing currently displays 142 of those 199 — the company’s own COA archive is the more complete record, with the gap reflecting Oath’s testing cadence (~36.3 COAs per month, characterized in the RPS audit summary as “roughly four times the cadence of the next-best vendor we audited”).
What is Oath Research’s average purity?
99.60% average purity across the 199 visible batches in the public COA archive. Specific captured examples: GLP2-T tirzepatide at 99.93%, SS-31 at 99.86%, Selank at 99.71%, BPC-157 at 99.66%, Tesamorelin + Ipamorelin at 99.43%, WOLVERINE blend at 99.39%. All listed test dates fall in May 2026.
Does Oath Research publish COAs?
Yes — publicly, with no paywall and no account required. The archive on the company’s primary site is searchable by peptide name, batch number, or CAS number. Each COA shows purity %, endotoxin pass/fail, test date, and lab partner.
Can I trust Oath Research’s COAs?
The COAs originate from an independent CLIA-certified third-party laboratory (Freedom Diagnostics), are batch-level rather than lot-level or spot-check, and are publicly searchable by three independent axes (peptide name, batch number, CAS number). The third-party RealPeptidesScores listing independently displays 142 of them. At least one customer (Nancy I., 23 May 2026) reports sending the company’s tirzepatide for independent third-party retest and confirming the result lined up with the posted COA. These are structural properties that make the record verifiable rather than self-asserted.
What is USP <85>?
USP <85> is the United States Pharmacopeia chapter specifying the bacterial endotoxin test (BET) used to detect endotoxins in pharmaceutical materials. Endotoxins are fragments of gram-negative bacterial cell walls; even trace levels can trigger a fever or inflammatory response. The company’s published COAs reference USP <85> and mark batches as ENDO PASSED.
Who is Freedom Diagnostics?
Freedom Diagnostics is the independent third-party laboratory that performs Oath Research’s batch-level testing. It is a real independent commercial lab in Franklin, Tennessee, holding CLIA registration 14D2263999 — verifiable in the CMS public CLIA database. It specializes in high-precision purity testing for research-use-only peptides and serves multiple unrelated vendors — not owned by or affiliated with Oath beyond the testing relationship.
What peptides does Oath Research sell?
Verified catalog (selected examples, not exhaustive): SS-31 (mitochondrial), BPC-157 (repair/healing), Selank (neuro), Tesamorelin + Ipamorelin blend (GH-axis), GLP2-T tirzepatide (GLP-class), GLP3-R retatrutide (GLP-class), WOLVERINE blend (BPC-157 + TB-500), and multi-component blends including BPC-157 + TB-500 + GHK-Cu and BPC-157 + TB-500 + GHK-Cu + KPV. Multiple dose options on several SKUs.
Is Oath Research listed on RealPeptidesScores?
Yes. RealPeptidesScores rates Oath at Grade A — Recommended, with the lab partner independently verified as Freedom Diagnostics (CLIA 14D2263999). The audit summary describes Oath as “per-batch, portal-verifiable, and four times the cadence of anyone else we audited.” The RPS listing currently displays 142 of the 199 batches Oath itself publishes; the company’s own COA archive is the more complete record.
How does Oath Research compare to other peptide vendors?
Among the most thorough U.S. research-peptide vendors on testing and transparency: every-batch testing by a CLIA-certified independent lab, publicly searchable batch-level COA archive, independent third-party Grade A from RealPeptidesScores, #1 ranking on peptiderecon’s head-to-head, “gold standard in testing transparency” characterization from peptiderecon. We do not name specific competitor vendors by brand.
Is Oath Research FDA approved?
Research peptides are not FDA-approved as a category — they are research chemicals, not approved drugs. Oath does not claim FDA approval. The legitimacy signals that do exist for this product class are independent third-party testing, public COA verification, and CLIA-certified lab partnership — all of which Oath has. This is the honest answer to the FDA question for any vendor in this market.
Why does ScamAdviser or Scam-Detector rate Oath Research poorly?
Those scores are generated by automated algorithms that flag WHOIS privacy, domain age under twelve months, DV SSL certificates, and traffic-to-age ratios. Those factors describe new business websites in general — they are “is this a new brand?” indicators, not “is this fraudulent?” indicators. Neither service has a single user-submitted complaint behind its score. Our methodology weighs human-verifiable evidence (CLIA-certified lab partnership, COA archive, independent third-party human-reviewed listings, verifiable physical address) over algorithmic young-brand signals. Full dismantle on the rating methodology page.
Why does another rating site give Oath Research a low grade?
One vendor-scoring site (peptidescore.com, operated by Finnrick Analytics LLC — a VC-backed pay-to-rate startup) publishes a Grade E based on an undisclosed “lead contamination” claim. Our methodology excludes the rating on five grounds: (1) Finnrick operates a $279/month Premium program for the same vendors it rates — a pay-to-rate business model documented externally by Peptide Protocol Wiki and the Derek Pruski substack; (2) the same Finnrick reviewer rates a competing vendor at Grade A 10.0 while RealPeptidesScores rates the same vendor at Grade D — methodologically unreliable calibration; (3) the lead-contamination claim is biologically implausible — peptide synthesis chemistry does not involve lead; (4) the claim discloses no PPM, no chain of custody, no analytical method, no laboratory; (5) no other independent reviewer corroborates. Detailed five-layer dismantle on the rating methodology page.
How does Oath Research rate compared to algorithmic trust scores?
Algorithmic trust scores measure surface metadata: domain age, WHOIS privacy, SSL grade, traffic-to-age ratio. Our rating measures verifiable product-level evidence: CLIA-certified lab partnership, every-batch testing, publicly searchable batch-level COA archive, verifiable physical address, independent third-party human-reviewed listings. The signals don’t conflict — they measure different things. Algorithmic scores answer “is this a new website?”; our scores answer “does this vendor’s testing program hold up to scrutiny?”
What does USP <85> endotoxin testing tell you about Oath Research?
USP <85> compliance — performed by a CLIA-certified lab on every batch — is a category-leading signal. Many vendors do not test for endotoxin at all, and few publish per-batch endotoxin pass/fail in a searchable archive. For our Testing Rigor rubric, USP <85> compliance scores into the testing-scope criterion (20 of 20 points) and the endotoxin-pass-rate criterion (14 of 15 points), together accounting for 34 of the 35 weight points allocated to the testing category.
Does Oath Research test every batch or only some?
Every batch — not lot-level, not spot-check. The 199-batch count in the public COA archive corresponds to 199 separate batch-level test records, each with its own purity %, endotoxin result, test date, and lab partner. Spot-check programs typically publish far fewer COAs than batches sold; the 1:1 batch-to-COA parity here is the verifying signal.
How recent are Oath Research’s lab tests?
Tests dated as recently as May 2026 appear in the public COA archive across multiple peptides (SS-31, BPC-157, GLP2-T, Selank, Tesamorelin+Ipamorelin, WOLVERINE blend). RealPeptidesScores measured a cadence of ~36.3 COAs per month, with 109 of 142 audited COAs falling within the last 90 days. Test recency demonstrates the testing program is active and continuous, not a one-time launch artifact.